<!doctype html>
<style>
@charset "utf-8";
body {
	height: 100%;
	margin: 0;
	padding: 0;
}

.banner {
	position: fixed;
	top: 0;
	width: 100%;
	height: 65px;
	background: gray;
	line-height: 65px;
}
.spacer {
	height: 10px;
}

.main-content {
	padding: 5%;
}

.collapse_ACT {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-style: none solid none none;
	border-color: #B4045F;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_ACT + input{
	display: none;
}
.collapse_ACT + input + div{
	display: none;
}
.collapse_ACT + input:checked + div{
	display: block;
}
.ACT {
	text-align: justify;
	text-justify: inter-word;
}
.ACT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B4045F;
}
.ACT_collapse_similarity:hover{
	background: #e5d3dc;
}
.ACT_collapse_similarity + input {
	display: none;
}
.ACT_collapse_similarity + input + div{
	display: none;
}

.ACT_collapse_similarity + input:checked + div{
	display: block;
}
.ACT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.ACT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B4045F;
	padding-left: 5px;
}
.ACT_collapse_similarity:hover{
	background: #e5d3dc;
}
.ACT_collapse_similarity + input {
	display: none;
}
.ACT_collapse_similarity + input + div{
	display: none;
}
.ACT_collapse_similarity + input:checked + div{
	display: block;
}
.ACT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.ACT_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #B4045F;
}
.ACT_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_DOM {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-style: none solid none none;
	border-color: #B404AE;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_DOM + input{
	display: none;
}
.collapse_DOM + input + div{
	display: none;
}
.collapse_DOM + input:checked + div{
	display: block;
}
.DOM {
	text-align: justify;
	text-justify: inter-word;
}
.DOM_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B404AE;
	padding-left: 5px;
}
.DOM_collapse_similarity:hover{
	background: #e8d7e7;
}
.DOM_collapse_similarity + input {
	display: none;
}
.DOM_collapse_similarity + input + div{
	display: none;
}
.DOM_collapse_similarity + input:checked + div{
	display: block;
}
.DOM_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}.DOM_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #B404AE;
}
.DOM_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_EVO {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #7401DF;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_EVO + input{
	display: none;
}
.collapse_EVO + input + div{
	display: none;
}
.collapse_EVO + input:checked + div{
	display: block;
}
.EVO {
	text-align: justify;
	text-justify: inter-word;
}
.EVO_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #7401DF;
	padding-left: 5px;
}
.EVO_collapse_similarity:hover{
	background: #e2d7ed;
}
.EVO_collapse_similarity + input {
	display: none;
}
.EVO_collapse_similarity + input + div{
	display: none;
}
.EVO_collapse_similarity + input:checked + div{
	display: block;
}
.EVO_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.EVO_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #7401DF;
}
.EVO_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_RP {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #0174DF;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_RP + input{
	display: none;
}
.collapse_RP + input + div{
	display: none;
}
.collapse_RP + input:checked + div{
	display: block;
}
.RP {
	text-align: justify;
	text-justify: inter-word;
}
.RP_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #0174DF;
	padding-left: 5px;
}
.RP_collapse_similarity:hover{
	background: #c9d7e2;
}
.RP_collapse_similarity + input {
	display: none;
}
.RP_collapse_similarity + input + div{
	display: none;
}
.RP_collapse_similarity + input:checked + div{
	display: block;
}
.RP_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.RP_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #0174DF;
}
.RP_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_SIT {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #0489B1;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_SIT + input{
	display: none;
}
.collapse_SIT + input + div{
	display: none;
}
.collapse_SIT + input:checked + div{
	display: block;
}
.SIT {
	text-align: justify;
	text-justify: inter-word;
}
.SIT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #0489B1;
	padding-left: 5px;
}
.SIT_collapse_similarity:hover{
	background: #d0dfe2;
}
.SIT_collapse_similarity + input {
	display: none;
}
.SIT_collapse_similarity + input + div{
	display: none;
}
.SIT_collapse_similarity + input:checked + div{
	display: block;
}
.SIT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.SIT_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #0489B1;
}
.SIT_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_TU {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #04B486;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_TU + input{
	display: none;
}
.collapse_TU + input + div{
	display: none;
}
.collapse_TU + input:checked + div{
	display: block;
}
.TU {
	text-align: justify;
	text-justify: inter-word;
}
.TU_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #04B486;
	padding-left: 5px;
}
.TU_collapse_similarity:hover{
	background: #d0e2de;
}
.TU_collapse_similarity + input {
	display: none;
}
.TU_collapse_similarity + input + div{
	display: none;
}
.TU_collapse_similarity + input:checked + div{
	display: block;
}
.TU_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.TU_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #04B486;
}
.TU_similar > a {
	text-decoration: none;
	color: gray;
}

ul { 
	list-style-type: none;
	padding: 0;
	margin: 0;
}
ul li > a {
	text-decoration: none;
	color: gray;
}
ul li:hover, ul li:focus {
	background: #F0F0F0;
}

ul li:first-child span {
  border-left:none;  
}

</style>
<html>
<head>
<meta charset="utf-8">
<title>TF properties - BirA</title>
<meta name="theme-color" content="#ffffff">
</head>
<body>
	<div class="banner">
		<center><font color="white" size="16px" face="arial">BirA</font></center>
	</div>
	<div align="center" class="main-content">
		<div class="spacer">
	</div><br>			<label class="collapse_ACT" for="_1"><font size="5px">BirA transcriptional activity</font></label>
				<input id="_1" type="checkbox">
				<div class="ACT"><br><ul><li>aerobic to anaerobic anaerobic to aerobic ArgR CysB BirA DgsA MalT GadW MetJ NikR OxyR SoxR SoxS DcuR CueR FadR HcaR NtrC PhoB PurR SgrR TdcA TrpR ZraR ArcA CpxR CRP CusR FhlA Fis FNR Fur H-NS IHF IscR Lrp ModE NarL NrdR PdhR FlhDC GlcC EvgA GadX LeuO PspF RbsR steady states Figure 3 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=22870390" target="_blank">22870390</a>]<br></li>
<li>Positions corresponding to BirA aa25 , 29 , 31 , 36 , and 39 are often occupied by residues with large hydrophobic side chains ( Met , Leu , Ile , Val , or Trp ; Sauer et al. , 1982 ) , and , with the exception of position 39 , this homology was preserved in BirA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>This is the case for TyrR ,23 MalT ,24 BirA ,25 and NtrC .26 For eukaryotic nuclear receptors , including the vitamin D and retinoic acid receptors , regulatory ligands determine not only the oligomeric state of the receptor but als in ¯ uence the assembly of heterodimers of mixed receptor type , processes that have consequences for target site selection .27,28 In general , these effectorlinked assembly processes provide an indirect means of regulating DNA target-site occupancy , and ultimately transcriptional activity , via small changes in ligand concentration .25 One of the most interesting aspects of the Lrp regulon is the different regulatory patterns that relate to Lrp-leucine interactions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11575919" target="_blank">11575919</a>]<br></li>
<li>We identiﬁed a high proportion of TFs belonging to the AsnC , ArsR , MarR , TetR/AcrR , BirA , AraC/XylS , Fur , LysR , and PhoU families in bacteria and archaea .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15556475" target="_blank">15556475</a>]<br></li>
<li>Site-Specific Binding of holoBirA to Biotin Operator As indicated in Fig. 2 , binding of holoBirA to bioO results in the repression of transcription of the biotin biosynthetic genes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>These folding events are prerequisites to the dimerization required for tight binding of holoBirA to bioO .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>In this model a preformed holoBirA dimer binds to bioO , and the equation relating fractional saturation of bioO to holoBirA m o n o m e r concentration is as follows : Y - KKD + [ p ] 2 where KD is the equilibrium constant governing dimerization of the protein , K is the equilibrium constant governing binding of the dimer to the operator site , and the holoBirA concentration , [ P ] , is given in units of monomer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>The heat capacity change associated with the binding , obtained from the temperature dependence STRUCTURAL PARAMETERIZATION OF ENERGETICS OF BINDING OF BirA TOBio-5 ' - AM Ligand AG '' AHa & Apol & A , p - T ASsol , fl - T ASrfl - T ASconfa Bio-5 ' - AMP -13.9 -7.9 -640 -698 -12.0 2.3 3.6 Adapted with permissionfrom Y. Xu , C. R. Johnson , and D. Beckett , Biochemistry 34 , 5509 ( 1996 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>Binding of the effector to BirA results in disorder-to-order transitions in the flexible surface loops of the central domain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>It has its counterpart in GH5 , HNF-3 and HSF , but is reduced to a turn in CAP and BirA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8076591" target="_blank">8076591</a>]<br></li>
<li>It was therefore of interest to measure the solution assembly properties of BirA in its unliganded and adenylate-bound forms .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>In E. coli this two-step reaction is catalyzed by BirA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>Amino acid residues R118 , R119 , G142 , and D197 appear to be directly involved in the interactions between two BirA monomers .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>In this case the formation of biotinyl-5 ' - adenylate on the catalytic domain would change the relative positions of the structural domains and would enhance affinity of monomeric BirA for DNA in some unspecified manner .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>From the point of view of crystal growth , however , the concentration of BirA is very high and under these conditions the addition of biotin led to the dimeric form seen in the present structural analysis .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>Model building , coupled with biochemical data , suggests that this is the dimeric form of BirA that binds DNA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>One way to at least partially integrate the data available at the present time is to assume that BirA oligomerizes as it binds to DNA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>Further , several suppressors , including r3 , r7 , r13 , r16 , r24 , r26 , and r27 , are titrated and are partially or totally repressed with no added biotin at 42 ° C. Because titration implies that BirA is not overproduced , these suppressors are likely to affect D N A binding or corepressor concentration .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>Given the failure of simple equilibrium titrations to yield information about the energetics of interaction of BirA with bio-5 ' - AMP , an alternative approach utilizing transient kinetic techniques was developed to obtain this information .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>The structural data , together with mutational , biochemical and biophysical studies , suggest that the allosteric activator function of bio-59-AMP reflects its ability to induce disorder-to-order transitions in multiple segments of BirA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>As indicated in the figure legend , the experiment is performed by first mixing BirA and bio-5 ' - AMP at roughly a 1:1 molar ratio , allowing the intermediate or collision complex to be maximally populated , and then mixing in a large molar excess of the competitive ligand , biotin .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>Therefore , k2 is roughly equal to the value of ( k2 + k-2 ) or 0.3 sec-1 , determined from the initial kinetic analysis of association of BirA and bio-5 ' - AMP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>A general equation relating the bio-5 ' - AMP concentration to time is as follows : where [ bio-5 ' - AMP ] t is the adenylate concentration at time t in the synthetic time course , n is the stoichiometry of the complex formed in the initial burst of adenylate synthesis , and [ BirA ] 0 is the total BirA concentration in the reaction .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>35 '36 A representative time course of association of BirA with bio-5 ' - AMP is shown in Fig. 5 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>These measurements took advantage of the enzymatic activity of BirA and were based on determinations of the time course of BirA-catalyzed synthesis of bio-5 ' - AMP from biotin and ATP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>R. Cronan , Jr. , Cell 58 , 527 ( 1989 ) BirA + AMP + holoBCCP ~ ~ BirA-bio-5 ' - AMP -- bioO FiG. 1 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>Phosphor-imaging of the plate revealed the presence of biotinyl-59-AMP and quantitation of the images revealed the presence of a burst Abbreviation : BirA , biotin repressor ; bioO , biotin operator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>P - BirA + bio-5 ' - AMP BirA-bio-5 ' - AMP An N-terminal domain deletion mutant of the biotin repressor has been constructed ( BirA65-321 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>The following chemical model is consistent with these observations : BirA + bio-5 ' - AMP ~ BirA-bio-5 ' - AMP '' .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>35 The following chemical equation describes the process : BirA + biotin + ATP ksyn ) BirA-bio-5 ' - AMP k ° ff > BirA + bio-5 ' - AMP ( 5 ) The rapid exponential phase is governed by the pseudo first-order rate constant , ksyn .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>The affinity of bio-5 ' - AMP for BirA is high , and attempts to estimate the binding energetics using a straightforward equilibrium fluorescence titration were not successful .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>The combined results indicate that binding of bio-5-AMP to BirA is both enthalpically and entropically favored in the temperature range of 10-40 ° ( Fig. 9 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>It is thought that binding of BirA to the 40-bp biotin operator ( bioO ) sequence25prevents transcription initiation by a simple occlusion mechanism in which binding of RNA polymerase to the two promoters is blocked when BirA-bio-5 ' - AMP is bound to bioO .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>Assuming that the enhancement of affinity of BirA for bioO associated with binding of either bio-59-AMP or biotin reflects only the activities of these ligands in promoting protein dimerization , the equilibrium dissociation constant , KD , for dimerization of the biotin complex of BirA can be estimated .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>Two holoBirA ( BirAzbio-59-AMP ) mono-mers bind cooperatively to the biotin operator , a process in which bio-59-AMP activates BirA for DNA binding by promoting its homodimerization ( 6 , 7 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>Although it has been suggested that biotin binding can also activate DNA binding by BirA ( 19 ) , previously published results of sedimentation equilibrium measurements of BirA indicate that the binding of bio-59-AMP , not biotin , is coupled to dimerization of the repressor ( 7 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>As shown in Table II , when BM6044 was transformed with pKB11B alone , the added biotin and the defective BirA repressor provided by BM6044 could only repress the operon slightly .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1659455" target="_blank">1659455</a>]<br></li>
<li>BirA binds to the biotin operon , repressing its transcription , via this domain ~ Buoncristiani et al. , 1986 ; Wilson et al. , 1992 !	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11106165" target="_blank">11106165</a>]<br></li>
<li>The properties of the BirA protein result in an unusually sophisticated regulatory system , in which transcription of the regulated operon responds not only to the supply of biotin , the product synthesized by the enzymes encoded by the operon genes , but also to the supply of the protein to which biotin must be attached for its biological function .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2667763" target="_blank">2667763</a>]<br></li>
<li>The repressor of biotin biosynthesis/biotinholoenzyme ligase ( BirA ) catalyzesthe two-step posttranslational biotinylation of the biotin carboxyl carrier protein subunit ( BCCP ) , reactions I and II , and binds noncovalently to the biotin operator , bioO , to repress transcription initiation at the biotin biosynthetic operon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>In Escherichia coli , biotinylation is catalyzed by the BirA protein , which also represses the transcription of the biotin operon , using the ligase reaction intermediate biotinyl-AMP as a co-repressor ~ Barker & Campbell , 1981 ; Cronan , 1989 !	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11106165" target="_blank">11106165</a>]<br></li>
<li>Overview of bio Operon Regulation E. coli biotin-protein ligase , a protein of 33.5 kd called BirA , is the repressor protein that regulates transcription of the biotin operon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2667763" target="_blank">2667763</a>]<br></li>
<li>T he biotin repressor , BirA , is a critical protein in regulation of biotin retention and biosynthesis in Escherichia coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>The biotin ( bio ) operon in Escherichia coli is negatively regulated by BirA , a bifunctional protein with both repressor and biotin-activating functions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>The BirA prep ~ ation activated biotin in the presence of ATP to produce biotinyl-5 ' - adenylate , which either remained tightly bound to the protein and resulted in transcriptional repression , or was transferred to a lysine residue of the apoenzyme acetyl-CoA carboxylase ( Eisenberg et al. , 1982 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3899863" target="_blank">3899863</a>]<br></li>
<li>The level of biotin biosynthetic enzymes in the cell is controlled by the amount of biotinyl-5 ' - adenylate , which is the BirA corepressor .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>BirA activates biotin by converting it to biotinyl-5 ' - adenylate , the likely true corepressor of the biotin operon ( Prakash and Eisenberg , 1979 ; Barker and Campbell , 1981b ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3899863" target="_blank">3899863</a>]<br></li>
<li>If the biotin-accepting proteins are completely biotinylated , the biotinyl-5 ' - adenylate remains associated with BirA and acts as a corepressor ( Prakash and Eisenberg , 1979 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>Because BirA transfers the activated biotin to acetyfCoA carboxylase as a final step in the incorporation of biotin as an enzyme cofactor , it is a logical control point for the synthesis of biotin .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3899863" target="_blank">3899863</a>]<br></li>
<li>The multifunctional nature of BirA ensures that the cellular metabolic requirement for biotin and regulation of its biosynthesis are intimately coupled in the organism ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>The revertants appear to increase biotin activation by raising the specific activity of BirA and/or increasing the number of enzyme molecules .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>BirA is bifunctional , serving both as the biotin ( vitamin H ) - activating enzyme and as a transcriptional-regulator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>[ BirA ] , 5/xM ; [ biotin ] , 106/xM ; [ ATP ] , 50/zM .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>What conformational changes are required to transform BirA to an active repressor ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>Comparison of the apoBirA and BirAzbiotin complex structures illustrates how conformational changes in BirA lead to the dimerization required for tight DNA binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>To understand the conformational changes in BirA that occur on binding of the biotin ligand it is useful to compare the structures of the monomers of apoBirA and the BirAzbiotin complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>It was recently demonstrated that binding of BirA monomers to DNA is cooperative ( Dorothy Beckett personal communication ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>As expected ( see below ) , protection required binding of biotinoylAMP by BirA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2667763" target="_blank">2667763</a>]<br></li>
<li>Because BirA transfers biotin to a specific lysine residue of biotin carboxyl carrier protein , attempts were also made to soak crystals of BirA with biotinylated lysine , and these proved to be successful in locating the biotin binding site ( Fig. 3 Top ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>1 Although the catalytic functions of BirA are significant for funneling biotin into metabolism , the site-specific D N A binding function is required for the regulation of biotin biosynthesis .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>First , the unliganded or apo form of BirA is not active in site-specific binding to the biotin operator sequence .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>Interaction of BirA with Allosteric Effector , Biotinyl-5 ' - AMP As indicated in the introduction , BirA is activated for site-specific binding to the biotin operator by binding of the small molecule bio-5 ' - AMP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>The fact that biotin can serve as an allosteric-effector of binding of BirA to bioO supports the conclusion that the interface observed in this structure is relevant to that formed in the holoBirAzbioO complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>BirA represses transcription when biotinyl-5 ' - AMP is bound to the enzyme , suggesting that binding of corepressor helps form the BirA-DNA complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>The decreased dependence of repression on biotin concentration may be due to changes in BirA DNA-binding affinity , corepressor-binding affinity , the interaction between DNA-binding and corepressor-binding domains , or total concentration of either BirA or corepressor .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>The titration experiment would not detect an increase in the DNA-binding or corepressor-binding affinity of BirA , nor an increase in the amount of corepressor .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>BirA is a sequence-specific DNA-binding protein that also catalyzes the formation of biotinyl-5 ' - adenylate from biotin and ATP and transfers the biotin moiety to other proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>The dimerization that accompanies adenylate binding to BirA appears to be significant for site-specific binding of the protein to bioO .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>The adenylate is thus an allosteric activator in binding of BirA to DNA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>The data indicate that , although binding of the adenylate to BirA enhances the free energy of the protein -- DNA interaction by 5 kcalymole , biotin binding enhances it by only 3 kcalymole .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>There appear to be constraints on the BirA structure such that improvement in enzyme activity is accompanied by improved repression , perhaps resulting from the return to a structure more closely resembling the wild type , or by an increase in the amount of BirA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>Thus , even wild-type BirA must be expressed more than 150-fold in order for repression to occur at low biotin concentrations .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>Alternatively , birA707 may decrease the amount of wild-type BirA translated , explaining the constant low level of repression over a wide biotin concentration range .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>One model is based on altered ligand affinities and the other model explains repression by increased concentrations of BirA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>In the second model , the decrease in the slope and ordinate intercept of the repression curves is explained by increased concentrations of BirA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>Mutations in BirA that prevent growth at elevated temperatures presumably destabilize the protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>The increase in BirA concentration might result from increased transcription or translation of the birA gene , increased m R N A stability , a n d / o r increased protein stability .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>As expected , increased BirA protein levels gave increased repression at a given biotin concentration , and resulted in lower levels of basal expression ( super-repression ) , due to increased occupancy of the operator by BirA protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2667763" target="_blank">2667763</a>]<br></li>
<li>As expected from the model , derepression due to increased apoprotein supply was offset by an increased supply of BirA protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2667763" target="_blank">2667763</a>]<br></li>
				</div></ul><br>
			<label class="collapse_DOM" for="_2"><font size="5px">BirA protein domains</font></label>
				<input id="_2" type="checkbox">
				<div class="DOM"><br><ul><li>Superposition of the monomeric apoBirA structure on one of the subunits ( subunit B ) from the BirAzbiotin crystal structure yielded root-mean-square discrepancies between a-carbon atoms of 1.23 Å , 0.89 Å , 0.79 Å , and 1.26 Å for the N-terminal domain , the central domain , the C-terminal domain , and the entire molecule , respectively .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>The three loops , consisting of amino acid residues 110 -- 128 , 140 -- 146 , and 193 -- 199 , which are partially disordered in the apoBirA structure , are located in the dimerization interface .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>In the apoBirA structure ( 9 ) , residues within these loops ranged from partially to completely disordered .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>The structure ofBirA is highly asymmetric and consists of three domains .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>The crystal structure of apoBirA revealed that it is monomeric .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>In a noncooperative mechanism , two energetic parameters , AG1 and AG2 , th two intrinsic Gibbs free energies governing interaction of the a single holoBirA m o n o m e r with each half-site , adequately describe the binding data .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>The experimental data described earlier are not sufficient to independently resolve all three energetic terms associated with cooperative binding of holoBirA to the two half-sites of bioO .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>GH5 and HNF-3 have a three-stranded antiparallel , B-sheet with the third strand formed by the loop between helices I and II , whereas in LexA and BirA this loop runs approximately parallel to the n-sheet strands without forming part of the sheet .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8076591" target="_blank">8076591</a>]<br></li>
<li>Of the six proteins , CAP and BirA contain a classic HTH motif , while GH5 , HNF-3 and HSF , like LexA , have an insert in the turn between the helices .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8076591" target="_blank">8076591</a>]<br></li>
<li>GH5 , HNF-3 and HSF also have differences in the position and orientation of the first helix in the HTH motif relative to CAP , BirA and LexA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8076591" target="_blank">8076591</a>]<br></li>
<li>T h e rms deviativ between the three helices of OmpRc and BirA is 1.05 A , placing it within the CAP / LexAIBirA subfamily [ 41 ] .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9016718" target="_blank">9016718</a>]<br></li>
<li>T h e loops that connect helices a 2 with a 3 and helix a 3 with the C-terminal hairpin , however , are significantly larger in the case of OmpRc , with four and two amino acids in the loops of BirA versus ten and eight amino acids in the loops of OmpRc .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9016718" target="_blank">9016718</a>]<br></li>
<li>Results of enzymatic and chemical probing of the proteinzDNA complex are consistent with a structural model in which each DNA-binding domain of the holoBirA dimer contacts one of the two 12-bp sequences at the termini of the operator sequence ( 23 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>Amino acid residues R118 , R119 , G142 , and D197 appear to be directly involved in the interactions between two BirA monomers .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>Binding of the effector to BirA results in disorder-to-order transitions in the flexible surface loops of the central domain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>Tentative assignments of the functional domains of BirA have been made on the basis of the mutational data presented here .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>In the crystal structure , two adjacent mono-mers of BirA are in contact and are related by a twofold axis of symmetry ( Fig. 1 Right ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>The a-carbon at-oms of residues 22-42 of BirA superimpose on a-carbons 16-36 of Cro protein from phage A ( 14 ) with root-mean-square discrepancy of 0.91 A .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>The discrepancy between residues 22-42 of BirA with residues 169-189 of the catabolite gene activator protein ( 15 ) is 0.67 A .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>Sequence conservation among the three families is very poor , but a single lysine residue is strictly conserved in all of them , which , according to the available X-ray crystal structure of the E. coli BirA protein , is expected to contribute to the binding of lipoic acid in the LplA and LipB enzymes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11106165" target="_blank">11106165</a>]<br></li>
<li>In this case the formation of biotinyl-5 ' - adenylate on the catalytic domain would change the relative positions of the structural domains and would enhance affinity of monomeric BirA for DNA in some unspecified manner .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>The birA815 mutation changes the only cysteine residue in BirA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>The BirA monomer has approximate dimensions of 75 A x 35 A x 30 A and is organized in three domains ( Fig. 1 Left ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>The topology of the central domain of BirA ( Fig. 1 Left ) appears to be novel .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>We have previously shown that the XhoI linker-insertion mutation in plasmid pA20 , which inactivates repressor function , but maintains BHS activity , maps near a predicted helix-turn-helix region in the N-terminal portion of BirA ( Howard et al. , 1985 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>In addition , the nanomeric XhoI linker insertion ( Fig. 1 ) in the predicted BirA `` DNA sequence specificity '' helix further implicated the helix-turn-helix structure in repressor function .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>In order to study the interaction of the BirA enzymatic and DNA-binding domains , and to determine the protein contacts affecting enzyme-activity , spontaneous revertants of three BHS temperature-sensitive alleles ( birA 85 , birA 104 , and birA 879 ) were selected by recovery of BHS function at the non-permissive temperature .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>The results indicate that a predicted helix-turn-helix structure , from amino acid ( aa ) positions 18 to 39 within the 321-aa BirA protein , may be responsible for sequence-specific-DNA-binding , whereas the temperature-sensitive mutations affecting biotin activation are found in two regions from aa positions 83-l 19 and 189-235 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>DNA-binding and enzymatic domains of the bifunctional biotin operon repressor ~ BirA !	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11106165" target="_blank">11106165</a>]<br></li>
<li>The strongest primary sequence homology between BirA and the other DNA-binding domains was the seven common residues found in BirA and the A bacteriophage Cro protein ( Fig. 2 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>The predicted helix-turn-helix secondary structure of the proposed BirA DNA-binding domain is similar to those of other DNA-binding proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>( e ) Partially complementing mutations ( f ) The proposed BirA DNA-binding domain Fig. 1 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>In this paper , we have proposed a DNA-binding domain for the BirA protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>A helix-turn-helix DNA-binding domain for BirA could be constructed from the mutational data reported here and studies of other regulatory proteins ( Pabo and Sauer , 1984 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>DI occupies the N-terminus of BirA and encloses a DNA-binding helix-turn-helix motif .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11106165" target="_blank">11106165</a>]<br></li>
<li>Sequence comparisons with members of the DNA-binding helix-turn-helix family suggested that residues BirA a helix-turn-helix motif ( 13 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>T h e region of OmpRc predicted from mutational analyses to be involved in DNA-binding has a helix-turn-helix fold similar to that of some previously characterized DNA-binding proteins ( such as the biotin operon repressor BirA , catabolite gene activator protein CAP , and hepatocyte nuclear factor HNF-3y ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9016718" target="_blank">9016718</a>]<br></li>
<li>The resulting topology , which is similar to that found in the DNA-binding domains of other transcriptional regulatory proteins , including C A P 27 and LexA28 from E. coli and the eukaryotic proteins heat shock factor ( H S F ) 29 and hepatocyte nuclear factor 37 ( HNF3 ) , 3 ° places BirA in the winged-helix-turn-helix family .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>Mutations that affect the enzymatic activity of BirA occur at residues 107 , 115 , and 189 ( Table 2 ) , which are within 10 A of the crystallographically determined biotin binding site ( Fig. 1 Left ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>Because BirA transfers biotin to a specific lysine residue of biotin carboxyl carrier protein , attempts were also made to soak crystals of BirA with biotinylated lysine , and these proved to be successful in locating the biotin binding site ( Fig. 3 Top ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>The dimerization that accompanies adenylate binding to BirA appears to be significant for site-specific binding of the protein to bioO .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
				</div></ul><br>
			<label class="collapse_EVO" for="_3"><font size="5px">BirA evolution</font></label>
				<input id="_3" type="checkbox">
				<div class="EVO"><br><ul><li>We identiﬁed a high proportion of TFs belonging to the AsnC , ArsR , MarR , TetR/AcrR , BirA , AraC/XylS , Fur , LysR , and PhoU families in bacteria and archaea .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15556475" target="_blank">15556475</a>]<br></li>
<li>Sequence comparisons with members of the DNA-binding helix-turn-helix family suggested that residues BirA a helix-turn-helix motif ( 13 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>The resulting topology , which is similar to that found in the DNA binding domains of other transcriptional regulatory proteins , including C A P 27 and LexA28 from E. coli and the eukaryotic proteins heat shock factor ( H S F ) 29 and hepatocyte nuclear factor 37 ( HNF3 ) , 3 ° places BirA in the winged helix-turn-helix family .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
				</div></ul><br>
			<label class="collapse_RP" for="_4"><font size="5px">Processes regulated by BirA</font></label>
				<input id="_4" type="checkbox">
				<div class="RP"><br><ul><li>Only a subset of these enzymes , including BirA , also function as transcriptional repressors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>Table 1 TFs identiﬁed in complete genomes Family DBD Role PFAM Annotations Total 1 16 Function AlpA C n/d -- Lipopolysaccharide adhesion to human gastric tissue Tatusova et al. ( 1999 ) ; Odenbreit et al. ( 2002 ) AraC/XylS A M 733 124 813 Carbon metabolism , cell-wall-synthesis , stress responses , and pathogenesis regulation Arginine biosynthesis regulation Tobes and Ramos ( 2002 ) R 56 ArgR ArsR W 14 60 Campoy et al. ( 2002 ) 335 R W 50 313 Pérez - Rueda and Collado-Vides ( 2000 ) ; Sato and Kobayashi ( 1998 ) ; Diorio et al. ( 1995 ) Arsenic resistance regulation -- AslB n/d AsnC D 87 -- 39 72 -- w 277 Leucine repressor protein Biosynthesis of biotin Napoli et al. ( 1999 ) ; Leonard et al. ( 2001 ) Wilson et al. ( 1992 ) -- -- 24 0 BirA R CaiF n/d w 75 6 Co-activator of the carnitine operon Low temperature adaptation Buchet et al. ( 1998 ) Obokata et al. ( 1991 ) 201 -- 198 8 Cold shock CSD A Crl -- R 0 0 Schnetz ( 2002 ) Global regulator protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15556475" target="_blank">15556475</a>]<br></li>
<li>BirA therefore is involved in protein-protein ( BirA-BCCD ) as well as protein-DNA ( BirA-bioO ) interactions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9677289" target="_blank">9677289</a>]<br></li>
<li>T h e region of OmpRc predicted from mutational analyses to be involved in DNA binding has a helix-turn-helix fold similar to that of some previously characterized DNA-binding proteins ( such as the biotin operon repressor BirA , catabolite gene activator protein CAP , and hepatocyte nuclear factor HNF-3y ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9016718" target="_blank">9016718</a>]<br></li>
<li>BirA is a sequence-specific DNA-binding protein that also catalyzes the formation of biotinyl-5 ' - adenylate from biotin and ATP and transfers the biotin moiety to other proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>The increase in BirA concentration might result from increased transcription or translation of the birA gene , increased m R N A stability , a n d / o r increased protein stability .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>Gene , 44 ( 1986 ) 255-261 Elsevier GENE 1660 DNA-binding and enzymatic domains of the bifunctional biotin operon repressor ( BirA ) of Escherichia coli ( DNA-protein interactions ; biotin holoenzyme synthetase ; fatty-acid-synthesis ; nucleotide sequence analysis ) Martin R. Buoncristiani , Peter K. Howard * and Anthony J. Otsuka ** Department of Genetics , 345 Murford Hall , Universityof Calgornia , Berkeley , CA 94720 ( U.S.A. ) Tel. (415)642-9545 ( Received March 4th , 1986 ) ( Revision received April 26th , 1986 ) ( Accepted May lst , 1986 ) SUMMARY The negative regulation of the biotin biosynthetic ( bio ) operon in Escherichia coli is mediated by the bifunctional b & A gene product , which serves as the bio repressor and biotin-activating enzyme .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>The biotin operon of E. coli and other enteric bacteria is a more striking example of regulation , where the transcriptional regulatory protein ( BirA ) is also the enzyme ( biotin-protein ligase ) that catalyzes the covalent attachment of the essential vitamin , biotin , to certain proteins involved in key metabolic carboxylation and decarboxylation reactions ( See figure ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2667763" target="_blank">2667763</a>]<br></li>
<li>In Escherichia coli , biotinylation is catalyzed by the BirA protein , which also represses the transcription of the biotin operon , using the ligase reaction intermediate biotinyl-AMP as a co-repressor ~ Barker & Campbell , 1981 ; Cronan , 1989 !	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11106165" target="_blank">11106165</a>]<br></li>
<li>Overview of bio Operon Regulation E. coli biotin-protein ligase , a protein of 33.5 kd called BirA , is the repressor protein that regulates transcription of the biotin operon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2667763" target="_blank">2667763</a>]<br></li>
<li>The biotin operon repressor , BirA , is 33.5-kDa protein that a regulates transcription of the Escherichia coli biotin operon ( 1-3 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1409631" target="_blank">1409631</a>]<br></li>
<li>T he biotin repressor , BirA , is a critical protein in regulation of biotin retention and biosynthesis in Escherichia coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>The key protein component of the system is the repressor of biotin-biosynthesis or BirA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>** To whom correspondence and reprint requests should be Abbreviations : aa , amino acid ( s ) ; BHS , biotin holoenzyme synthetase ; BirA , birA protein product ; bio operon , E. coli operon consisting of bioA ( leftward ) and bioBFCD ( rightward ) genes ; nt , nucleotide ( s ) ; RBS , ribosome-binding site ; wt , wild type .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>The birA gene encodes a bifunctional protein BirA that acts as the biotin operon represser and as the enzyme ( biotin holoenzyme synthetase ) which synthesizes the co-represser , biotinyl-5 ' - adeny-late [ 3,7 ] .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1659455" target="_blank">1659455</a>]<br></li>
<li>We chose the birA gene of Escherichia coli , located at 89 min on the genetic map , because it encodes a bifunctional 321 amino acid protein ( BirA ) that acts both as the acetyl-CoA carboxylase biotin holoenzyme synthetase ( BHS ) and as the biotin operon repressor ( Campbell et al. 1972 ; Pai 1972 ; Barker and Campbell 1980 , 1981a , b ; Eisenberg etal .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>Genetic ( Barker and Campbell , 1981a , b ) , biochemical ( Eisenberg et al. , 1982 ) and nt sequence studies ( Howard et al. , 1985 ) have shown that the birA gene encodes a bifunctional 321-aa protein ( BirA ) that acts both as the biotin operon repressor and as the enzyme , acetyl-CoA carboxylase BHS ( EC 6.3.4.15 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
				</div></ul><br>
			<label class="collapse_SIT" for="_5"><font size="5px">BirA binding site</font></label>
				<input id="_5" type="checkbox">
				<div class="SIT"><br><ul><li>u birA331 I 35 40 [ Ala Ala Ile Asn LYS His m Gln Gln Thr Val Ser Arg Val Val Asn Val m Asn Gly Ser Asn Leu Phe Asn Ala m His m Gln Tyr Asp Val BirA LacI GalR TrpR CI Cro Lys Asp Val Ala Arg Leu Ar Glu Lys Asn Glu rc $ lu Ser Ala Asp Lys Tyr Lys Thr Ala Lys Asp *** === Ala Ile/Val GUY DNA Backbone Binding Helix DNA Sequence Specificity Helix Fig. 2 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>Conclusions The BirA protein is a remarkably efficient use of a coding sequence .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2667763" target="_blank">2667763</a>]<br></li>
<li>complex indicates that at least 40 bp are altered in their susceptibility to enzyme-catalyzed hydrolysis as a consequence of holoBirA binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9750231" target="_blank">9750231</a>]<br></li>
<li>Two of the hypersensitive sites are located in each of the 12-bp termini that contact each holoBirA monomer and the third is in the sequence adjacent to the A-tract that constitutes the core of the operator sequence .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>Two holoBirA monomers bind to the 40-bp biotin operator sequence ( 6 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
<li>Thermodynamic measurements of DNA binding indicate that two holoBirA mono-mers bind cooperatively to the biotin operator sequence ( 6 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11353844" target="_blank">11353844</a>]<br></li>
				</ul></div><br>
			<label class="collapse_TU" for="_6"><font size="5px">Transcription unit regulated by BirA</font></label>
				<input id="_6" type="checkbox">
				<div class="TU"><br><ul><li>The properties of the BirA protein result in an unusually sophisticated regulatory system , in which transcription of the regulated operon responds not only to the supply of biotin , the product synthesized by the enzymes encoded by the operon genes , but also to the supply of the protein to which biotin must be attached for its biological function .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2667763" target="_blank">2667763</a>]<br></li>
<li>BirA activates biotin by converting it to biotinyl-5 ' - adenylate , the likely true corepressor of the biotin operon ( Prakash and Eisenberg , 1979 ; Barker and Campbell , 1981b ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3899863" target="_blank">3899863</a>]<br></li>
<li>In Escherichia coli , biotinylation is catalyzed by the BirA protein , which also represses the transcription of the biotin operon , using the ligase reaction intermediate biotinyl-AMP as a co-repressor ~ Barker & Campbell , 1981 ; Cronan , 1989 !	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11106165" target="_blank">11106165</a>]<br></li>
<li>** To whom correspondence and reprint requests should be Abbreviations : aa , amino acid ( s ) ; BHS , biotin holoenzyme synthetase ; BirA , birA protein product ; bio operon , E. coli operon consisting of bioA ( leftward ) and bioBFCD ( rightward ) genes ; nt , nucleotide ( s ) ; RBS , ribosome-binding site ; wt , wild type .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3536662" target="_blank">3536662</a>]<br></li>
<li>We chose the birA gene of Escherichia coli , located at 89 min on the genetic map , because it encodes a bifunctional 321 amino acid protein ( BirA ) that acts both as the acetyl-CoA carboxylase biotin holoenzyme synthetase ( BHS ) and as the biotin operon repressor ( Campbell et al. 1972 ; Pai 1972 ; Barker and Campbell 1980 , 1981a , b ; Eisenberg etal .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3325774" target="_blank">3325774</a>]<br></li>
<li>The birA gene encodes a bifunctional protein BirA that acts as the biotin operon represser and as the enzyme ( biotin holoenzyme synthetase ) which synthesizes the co-represser , biotinyl-5 ' - adeny-late [ 3,7 ] .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1659455" target="_blank">1659455</a>]<br></li>
				</div></ul></div><br>
	</div>
</body>
</html>